Windlas Biotech Limited has informed the Exchange regarding 'Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Windlas Biotech has submitted a disclosure to NSE under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations. The full text of the intimation has not been provided in this filing, so the specific subject matter is not clear from the available information. Regulation 30 filings are mandatory disclosures used by listed companies to inform the exchange about material events such as board decisions, agreements, acquisitions, or changes in management. Shareholders will need to wait for further details or the company's detailed communication to understand what triggered this disclosure.
Without the actual content of the intimation, it is not possible to determine any direct impact on shareholders or the stock. Investors should look for the company's accompanying press release or exchange filing for the full details.